Electrolyte Imbalances and Cardiac Arrhythmias
Introduction to Electrolyte Imbalances
- Both hypokalemia and hyperkalemia are primary electrolyte imbalances that cause palpitations and cardiac arrhythmias, with hypokalemia being the most common electrolyte abnormality encountered clinically, while magnesium abnormalities also contribute to arrhythmogenesis 1, 2
Hypokalemia
- Arrhythmias associated with hypokalemia include premature ventricular contractions, ventricular tachycardia, torsades de pointes, ventricular fibrillation, cardiac arrest, first or second-degree atrioventricular block, and atrial fibrillation 1, 2
- Patients with heart failure should maintain potassium levels ≥4 mEq/L to prevent arrhythmias 1, 2, 3
- ECG findings in hypokalemia include broadening of T waves, ST-segment depression, and prominent U waves (>1 mm) 1, 2, 3
Hyperkalemia
- Hyperkalemia is one of the few potentially lethal electrolyte disturbances that can directly cause cardiac arrest 4, 5, 6
- Severe hyperkalemia (>6.5 mmol/L) occurs most commonly from renal failure or release of potassium from cells 4, 5, 6
- Progressive ECG changes by potassium level include peaked T waves at 5.5-6.5 mmol/L, flattened or absent P waves and prolonged PR interval at 6.5-7.5 mmol/L, and widened QRS complex at 7.0-8.0 mmol/L 4, 5, 6, 3
- ECG manifestations of hyperkalemia vary significantly among individuals and may not be predictable, requiring careful clinical correlation 2, 7, 3
Magnesium Abnormalities
- Magnesium bolus or infusion is recommended for torsades de pointes regardless of baseline magnesium level 7, 3
- Hypomagnesemia contributes to QT prolongation and increases risk of torsades de pointes, even when magnesium levels appear normal 7, 3
- Hypermagnesemia can cause prolonged PR, QRS, and QT intervals, and severe cases may result in atrioventricular nodal conduction block, bradycardia, hypotension, and cardiac arrest 7, 3
Monitoring Recommendations
- Continuous ECG monitoring is indicated for moderate to severe potassium or magnesium imbalances, any electrolyte abnormality with ECG changes, patients with cardiac comorbidities and electrolyte disturbances, and during treatment of severe electrolyte abnormalities 1, 2, 3, 4, 7